Yep, and Sensera's margins are 51% moving to 60% over the next 6 months, which is higher than Abiomeds' allbeit off a much smaller dollar amount.
We have a whole heap of MEM's clients being added to our list of clients. Once we are embedded its very hard to to get rid of us. Also, it has been explained to me that as in the case of Abiomed we have made improvements to the sensors supplied that we have then patented. So we are truely imbedded into their supply chain. What a great reference point Abiomed is for future possible MEM's clients.
But, the name of the game in terms of huge revenue growth is location awareness and that is going to be ramped up significantly come January by Zoetis/Smartbow who want to make a quick grab of market share in North America.
I am confident that with Ralph now in full swing that we will have revenue upgrades towards the end of the March quarter for the FY.
- Forums
- ASX - By Stock
- SE1
- Ann: Sensera Investor Conference Call - audio recording available
Ann: Sensera Investor Conference Call - audio recording available, page-5
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SE1 (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online